Reuters logo
BRIEF-ClinicalTrials.gov says Janssen's study of niraparib suspends recruitment
June 9, 2017 / 2:55 PM / 3 months ago

BRIEF-ClinicalTrials.gov says Janssen's study of niraparib suspends recruitment

June 9 (Reuters) - ClinicalTrials.gov:

* Janssen Research’s study of niraparib in men with metastatic castration-resistant prostate cancer, DNA-repair anomalies suspended recruitment

* Current participants in Janssen Research's study of niraparib remain active and on study treatment Source text - (bit.ly/2r2uR15)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below